November 19, 2021
3 mins read

110 countries recognise India’s Covishield, Covaxin

Of eight WHO-approved vaccines against Covid-19 in emergency use listing, two vaccines — Covaxin and Covishield — are from India….reports Asian Lite News

As of now as many as 110 countries have recognized India’s Covid vaccines — Covishield and Covaxin — and have agreed to mutual recognition of Covid-19 vaccination certificates with India, said official sources in the Union Health Ministry.

A source with the Ministry said that at present, 110 countries have agreed to mutual recognition of vaccination certificates and those who recognise Indian vaccination certificates of travellers fully vaccinated with Covishield or World Health Organisation(WHO)-approved Covid vaccines.

As per the new travel guidelines issued by the Union Health Ministry, if a fully vaccinated traveller is coming from a country with which India has reciprocal arrangements for mutual acceptance of WHO-approved Covid-19 vaccines, they will be allowed to leave the airport and must self-monitor their health for 14 days’ post arrival.

If partially or not vaccinated travellers visit India, they will have to submit their sample for post-arrival Covid-19 test at the point of arrival after which they will be allowed to leave the airport. They will have to be undergo home quarantine for seven days and undertake re-test on the eighth day of arrival in India and if found negative, further self-monitor their health for next seven days.

“Travellers arriving from countries excluding those at risk, will be allowed to leave the airport and must self-monitor their health for 14 days’ post arrival. This is applicable to travellers from all countries, including with which reciprocal arrangements for mutual acceptance of WHO-approved Covid-19 vaccines also exist,” said the new international arrival guidelines.

Of eight WHO-approved vaccines against Covid-19 in emergency use listing, two vaccines — Covaxin and Covishield — are from India.

‘Developing Covaxin was a challenge’

Bharat Biotech Director, V. Krishna Mohan, has said developing the Covaxin in “just 10 months” was an enormous challenge.

Addressing a session on Thursday at the Bengaluru Tech Summit-2021, he said there were no vaccines when the Covid-19 hit India, and the world.

“This was a daunting challenge for the pharma sector and the prospective vaccine makers. We were given just 10 months to develop a vaccine to fight the infection but we could succeed in developing Covaxin swiftly at a level within these few months,” he said.

The Central government took the right steps at that juncture, the Bharat Biotech Director added.

“There were no such past precedents and it seems impossible to make a vaccine in such a short span of time,” he said.

The company chalked out a plan to make and develop the vaccine in India, he added.

V. Krishna Mohan further said it is difficult to quantify the hard work that went into the making of the vaccine, adding the company did not compromise on the quality or efficacy of the vaccine at any point of time.

He said Bharat Biotech was successful in releasing Covaxin in a record time and helped to save lives of crores of fellow Indians.

The Indian Council of Medical Research has positively changed its style of functioning in the last decade, he added.

Participating in the session, Deepak Sapra, CEO, API & Services, Dr Reddy’s Laboratories, said: “Covid has taught us tough lessons. With the help of our Russian partner we could develop ‘Sputnik V’ vaccines which not only helped India but also other developed countries. However, in respect of vaccine development it is a long way to go for India and Indian pharma companies.”

Divya Bizwan, Senior Vice-President of Aurobindo Pharma, said there was no dearth of talent in India.

“But, there is hardly any recognition for talent in pharma companies. It is necessary for vaccine makers to recognize this need and be more encouraging to the pool of talent that Indian pharma sector has.”

Atin Tomar, CEO of Yapan Bio, also participated in the session.

ALSO READ: Modi cautions on cryptocurrency, says nations need to work together

Previous Story

Christian Michel urges govt to impose sanctions against India

Next Story

IAF to get two simulators for Jaguar aircraft for Rs 357 cr

Latest from -Top News

No Talks Till Terror Ends: India to Pakistan

The MEA’s strong response came at a time when Pakistan, pushed on the backfoot by India’s decisive Operation Sindoor, has suddenly started talking about its intent on having peace talks with India….reports

BNP ramps up poll demand

Chief Adviser Yunus had earlier promised elections in December 2025, but the timeline has since been pushed back first to February 2026 and then to June 2026, fuelling suspicion and dissatisfaction among

Saudi backs India’s strategic outreach

In a series of engagements, the Indian delegation met Saudi Arabia’s Minister of State Adel Al-Jubeir and other senior officials. A high-profile Indian all-party parliamentary delegation, led by BJP MP Baijayant Jay

India clears stealth fighter project

New execution model paves way for private sector involvement in India’s ambitious stealth aircraft programme; Army showcases next-gen drone warfare systems. In a landmark decision bolstering India’s defence self-reliance, Defence Minister Rajnath

ASEAN lauds India’s firm stance on terrorism

The ASEAN Secretary-General reaffirmed the bloc’s resolve to deepen collaboration with India—a comprehensive strategic partner—in security and counter-terrorism efforts. The Indian all-party Parliamentary delegation, led by Janata Dal (United) MP Sanjay Jha,
Go toTop

Don't Miss

Indian apparel Industry staring at Lankan crisis

Production in Sri Lanka of hosiery items for exports has

KCR set to take on BJP

Aiming for a third victory at the hustings in 2023,